These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 6488555

  • 1. The relationship between urinary inhibitory activity and endogenous concentrations of glycosaminoglycans and uric acid: comparison of urines from stone-formers and normal subjects.
    Ryall RL, Marshall VR.
    Clin Chim Acta; 1984 Aug 31; 141(2-3):197-204. PubMed ID: 6488555
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Investigation of GAGS on 24-hour and 2-hour urines from calcium oxalate stone formers and healthy subjects.
    Gianotti M, Genestar C, Palou A, Pons A, Conte A, Grases F.
    Int Urol Nephrol; 1989 Aug 31; 21(3):281-8. PubMed ID: 2807779
    [Abstract] [Full Text] [Related]

  • 4. Urinary risk factors in calcium oxalate stone disease: comparison of men and women.
    Ryall RL, Harnett RM, Hibberd CM, Mazzachi BC, Mazzachi RD, Marshall VR.
    Br J Urol; 1987 Dec 31; 60(6):480-8. PubMed ID: 3427328
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Uric acid and its relationship with glycosaminoglycans in normal and stone-former subjects.
    Conte A, Roca P, Genestar C, Grases F.
    Nephron; 1989 Dec 31; 52(2):162-5. PubMed ID: 2500615
    [Abstract] [Full Text] [Related]

  • 7. A method for discrimination between calcium oxalate kidney stone formers and normals.
    Sarig S, Garti N, Azoury R, Wax Y, Perlberg S.
    J Urol; 1982 Sep 31; 128(3):645-9. PubMed ID: 6214645
    [Abstract] [Full Text] [Related]

  • 8. The effect of urine, pyrophosphate, citrate, magnesium and glycosaminoglycans on the growth and aggregation of calcium oxalate crystals in vitro.
    Ryall RL, Harnett RM, Marshall VR.
    Clin Chim Acta; 1981 May 31; 112(3):349-56. PubMed ID: 6263523
    [Abstract] [Full Text] [Related]

  • 9. Urinary glycosaminoglycans as risk factors for uric acid nephrolithiasis: case control study in a Sardinian genetic isolate.
    Ombra MN, Casula S, Biino G, Maestrale G, Cardia F, Melis P, Pirastu M.
    Urology; 2003 Sep 31; 62(3):416-20. PubMed ID: 12946738
    [Abstract] [Full Text] [Related]

  • 10. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
    Robert M, Boularan AM, Delbos O, Guiter J, Descomps B.
    Urol Int; 1998 Sep 31; 60(1):41-6. PubMed ID: 9519420
    [Abstract] [Full Text] [Related]

  • 11. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ, Coe FL.
    Scand J Urol Nephrol Suppl; 1980 Sep 31; 53():171-7. PubMed ID: 6937993
    [Abstract] [Full Text] [Related]

  • 12. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation.
    Freitas AM, Schor N, Boim MA.
    BJU Int; 2002 Jun 31; 89(9):829-34. PubMed ID: 12010223
    [Abstract] [Full Text] [Related]

  • 13. [Effect of proteolytic enzymes, electrolytes and other factors on the crystallization of calcium oxalate in the urine].
    Börner RH, Brundig P, Mäurer F, Berg W, Baumann W.
    Z Urol Nephrol; 1983 May 31; 76(5):327-31. PubMed ID: 6224367
    [Abstract] [Full Text] [Related]

  • 14. Separate effects of urinary chondroitin sulphate and heparan sulphate on the crystallization of urinary calcium oxalate: differences between stone formers and normal control subjects.
    Shum DK, Gohel MD.
    Clin Sci (Lond); 1993 Jul 31; 85(1):33-9. PubMed ID: 8149691
    [Abstract] [Full Text] [Related]

  • 15. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization.
    Kalaiselvi P, Udayapriya KL, Selvam R.
    BJU Int; 1999 Jun 31; 83(9):919-23. PubMed ID: 10368229
    [Abstract] [Full Text] [Related]

  • 16. The excretion of glycosaminoglycans in the urine of calcium-oxalate-stone patients and healthy persons.
    Hesse A, Wuzel H, Vahlensieck W.
    Urol Int; 1986 Jun 31; 41(2):81-7. PubMed ID: 3727195
    [Abstract] [Full Text] [Related]

  • 17. Urinary urate and uric acid relative saturation in normouricuric calcium oxalate stone formers with normal urinary calcium oxalate saturation.
    Labeeuw M, Gerbaulet C, Pozet N, Zech P, Traeger J.
    Adv Exp Med Biol; 1980 Jun 31; 122A():87-92. PubMed ID: 7424663
    [No Abstract] [Full Text] [Related]

  • 18. Calcium oxalate crystallization in urine: role of urate and glycosaminoglycans.
    Grover PK, Ryall RL, Marshall VR.
    Kidney Int; 1992 Jan 31; 41(1):149-54. PubMed ID: 1593851
    [Abstract] [Full Text] [Related]

  • 19. The role of glycosaminoglycans and uric acid in idiopathic calcium nephrolithiasis.
    Baggio B, Gambaro G, Marchi A, Cicerello E, Favaro S, Borsatti A.
    Contrib Nephrol; 1984 Jan 31; 37():5-8. PubMed ID: 6713879
    [No Abstract] [Full Text] [Related]

  • 20. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG, Bek-Jensen H, Fornander AM, Nilsson MA.
    J Urol; 1995 Sep 31; 154(3):940-6. PubMed ID: 7637098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.